Skip to main content
    A

    Amphastar P (AMPH)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $29.17
    -0.20 (-0.68%)

    Market Cap: $1.25B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Amphastar P (AMPH) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Amphastar P (AMPH) trades at 10.3x trailing earnings and 1.7x sales. Its P/E of 10.3x is below its 5-year median of 12.4x. The median P/E across 11 similar companies is 12.7x.

    Current Multiples

    Its enterprise value is 7.6x its EBITDA. Its free cash flow yield is 11.2%.

    MultipleValue
    P/E (trailing)10.3x
    Forward P/EN/A
    Price to sales1.7x
    Price to book1.5x
    EV/EBITDA7.6x
    Price to FCF8.9x
    EV/FCF11.9x
    PEG2.8
    FCF yield11.2%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 56.5% below 23.7x, its P/S is 41.4% below 2.9x and its P/B is 40.0% below 2.5x.

    MultipleCurrent5-year median10-year median
    P/E10.3x12.4x23.7x
    P/S1.7x3.0x2.9x
    P/B1.5x2.9x2.5x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 8.8x in 2025 to 86.5x in 2018. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$26.788.8x1.7x1.6x
    2024$37.139.6x2.5x2.6x
    2023$61.8518.7x4.8x5.1x
    2022$28.0214.2x2.8x2.7x
    2021$23.2917.1x2.6x2.6x
    2020$20.1131.4x2.7x2.4x
    2019$19.2955.1x2.8x2.4x
    2018$19.9086.5x3.2x2.9x
    2017$19.2452.0x3.8x2.8x
    2016$18.4236.8x3.3x2.6x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About AMPH

    Is AMPH stock overvalued?

    GNG's valuation label for AMPH is Undervalued. Its P/E of 10.3x compares with a median of 12.7x across 11 similar companies.

    What is AMPH's price to sales ratio?

    Amphastar P has a price to sales ratio of 1.7x.

    What is Amphastar P's average P/E ratio over 5 years?

    Amphastar P's median P/E over the last 5 years is 12.4x, from 60 month-end values through Oct 2026.

    What is AMPH's PEG ratio?

    Amphastar P has a PEG ratio of 2.8.